Skip to main content
. 2014 Mar;58(3):1410–1419. doi: 10.1128/AAC.02136-13

FIG 2.

FIG 2

alamarBlue reduction as a basis for a prodrug screen. The prodrugs nitrofurazone (NFZ) and nitrofurantoin (NFT), protonophore CCCP, ciprofloxacin (CIP), and kanamycin (KAN) were added at 50 μg/ml to wells of a microtiter plate containing alamarBlue and E. coli cells. Fluorescence was detected using a excitation wavelength at 544 nm and emission wavelength at 590 nm. Values are means ± standard deviations (SD) (error bars). Data are representative of three independent trials.